Safety and efficacy of liraglutide on reducing visceral and ectopic fat in adults with or without type 2 diabetes mellitus: A systematic review and meta‐analysis
Safety and efficacy of liraglutide on reducing visceral and ectopic fat in adults with or without type 2 diabetes mellitus: A systematic review and meta‐analysis
复制标题
DOI：
10.1111/dom.14908
复制
发表时间：
2022-10
期刊：
影响因子：
7.7
通讯作者：
Fengling He;Wei Chen;Wenlong Xu;Dan Liu;Zhiwen Xiao;Yating Tang;Zhongqiu Lin;Y. Liao;J. Bin;Guojun Chen;Yanmei Chen
中科院分区：
文献类型：
--
作者：
Fengling He;Wei Chen;Wenlong Xu;Dan Liu;Zhiwen Xiao;Yating Tang;Zhongqiu Lin;Y. Liao;J. Bin;Guojun Chen;Yanmei Chen
评估利拉鲁肽减少患有或不患有 2 型糖尿病 (T2DM) 成人的内脏脂肪和异位脂肪的有效性和安全性。
To assess the efficacy and safety of liraglutide to reduce visceral and ectopic fat in adults with or without type 2 diabetes mellitus (T2DM).